- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Tripotassium citrate monohydrate and potassium hydrogen carb
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Tripotassium citrate monohydrate and potassium hydrogen carbonate
| EU orphan designation number: | EU/3/17/1888
|
| Active ingredient: | Tripotassium citrate monohydrate and potassium hydrogen carbonate |
| Indication: | Treatment of distal renal tubular acidosis |
| Sponsor: | Advicenne Pharma SA
2 rue Briçonnet, 30000 Nîmes, France |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 22/06/2017 | Orphan designation | EMA/OD/016/17 | (2017)4374 of 20/06/2017 |
CONTACT
EU links
Directorate General Health & Consumers